References

Alcala, A., Ramirez, G., Solis, A., Kim, Y., Tan, K., Luna, O., et al. (2020). Structural and functional characterization of three Type B and C chloramphenicol acetyltransferases from Vibrio species. Protein Science, 29(3), 695–710. https://doi.org/10.1002/pro.3796

Alcala, L., Ruiz-Garbajosa, P., & Cantón, R. (2020). Enzyme-based approaches to combat antibiotic resistance: Mechanisms and potential applications. Clinical Microbiology Reviews, 33(4), e00104-19. https://doi.org/10.1128/CMR.00104-19

Allen, H.K., Donato, J., Wang, H.H., Cloud-Hansen, K.A., Davies, J., & Handelsman, J. (2010). Call of the wild: Antibiotic resistance genes in natural environments. Nat Rev Microbiol, 8, 251–259. https://doi.org/10.1038/nrmicro2312

Altarac, D., Gutch, M., Mueller, J., Ronsheim, M., Tommasi, R., & Perros, M. (2021). Challenges and opportunities in the discovery, development, and commercialization of pathogen-targeted antibiotics. Drug Discov Today, 26, 2084–2089. https://doi.org/10.1016/j.drudis.2021.05.017

Aminov, R. I. (2021). Horizontal gene exchange in environmental microbiota. Frontiers in Microbiology, 12, 653030. https://doi.org/10.3389/fmicb.2021.653030

Andersson, D. I., & Hughes, D. (2014). Microbiological effects of sublethal levels of antibiotics. Nature Reviews Microbiology, 12(7), 465-478.https://doi.org/10.1038/nrmicro3270

Antimicrobial Resistance Collaborators. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet, 399(10325), 629–655. https://doi.org/10.1016/S0140-6736(21)02724-0

Baker, K. S., Dallman, T. J., Field, N., Childs, T., Mitchell, H., Day, M., et al. (2018). Horizontal antimicrobial resistance transfer drives epidemics of multiple Shigella species. Nature Communications, 9, 1462. https://doi.org/10.1038/s41467-018-03949-8

Baquero, F., Tedim, A. P., & Coque, T. M. (2013). Antibiotic resistance shaping multi-level population biology of bacteria. Frontiers in Microbiology, 4, 15.https://doi.org/10.3389/fmicb.2013.00015

Bhattacharyya, S., Walker, D. M., & Harshey, R. M. (2020). Dead cells release a ‘necrosignal’ that activates antibiotic survival pathways in bacterial swarms. Nature Communications, 11, 1–12. https://doi.org/10.1038/s41467-020-15969-7

Boyd, N.K., Teng, C., & Frei, C.R. (2021). Brief overview of approaches and challenges in new antibiotic development: A focus on drug repurposing. Front Cell Infect Microbiol, 11, 684515. https://doi.org/10.3389/fcimb.2021.684515

Brauner, A., Fridman, O., Gefen, O., & Balaban, N. Q. (2016). Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nature Reviews Microbiology, 14(5), 320–330. https://doi.org/10.1038/nrmicro.2016.34

Bryers, J. D. (2008). Medical biofilms. Biotechnology and Bioengineering, 100(1), 1-18.https://doi.org/10.1002/bit.21838

Butler, M. S., & Cooper, M. A. (2011). Antibiotics in the clinical pipeline in 2011. The Journal of Antibiotics, 64(6), 413-425.https://doi.org/10.1038/ja.2011.44

Candela, T., Marvaud, J. C., Nguyen, T. K., & Lambert, T. (2017). A cfr-like gene cfr(C) conferring linezolid resistance is common in Clostridium difficile. International Journal of Antimicrobial Agents, 50(4), 496–500. https://doi.org/10.1016/j.ijantimicag.2017.04.027

Candela, T., Pédron, T., Le Bouguénec, C., & Waksman, G. (2017). Protein-based therapeutic strategies against bacterial virulence. Current Opinion in Microbiology, 39, 100–105. https://doi.org/10.1016/j.mib.2017.10.006

Cano, V., March, C., Insua, J.L., Aguiló, N., Llobet, E., Moranta, D., et al. (2015). Klebsiella pneumoniae survives within macrophages by avoiding delivery to lysosomes. Cell Microbiol, 17, 1537–1560. https://doi.org/10.1111/cmi.12445

Chen, J., & Zhang, Y. (2020). Lysozymes: Hydrolyzing peptidoglycan in the bacterial cell wall. Applied Microbiology and Biotechnology, 104(2), 571-582. https://doi.org/10.1007/s00253-020-10571-8

Chernousova, S., & Epple, M. (2013). Silver as antibacterial agent: Ion, nanoparticle, and metal. Angewandte Chemie International Edition, 52(6), 1636-1653.https://doi.org/10.1002/anie.201205923

Chung, P. Y., & Toh, Y. S. (2014). Anti-biofilm agents: Recent breakthrough against multi-drug resistant Staphylococcus aureus. Pathogens and Disease, 70(3), 231-239.https://doi.org/10.1111/2049-632X.12141

Chung, W., & You, H. (2014). DNases: Disrupting extracellular DNA in biofilm and improving antibiotic efficacy. Biofilm Research, 1(2), 93-103. https://doi.org/10.1016/j.bioflm.2014.05.003

Coleman, S. R., Blimkie, T., Falsafi, R., & Hancock, R. E. W. (2020). Multidrug adaptive resistance of Pseudomonas aeruginosa swarming cells. Antimicrobial Agents and Chemotherapy, 64(3), e01999-19. https://doi.org/10.1128/AAC.01999-19

Davies, J., & Davies, D. (2010). Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews, 74(3), 417-433.https://doi.org/10.1128/MMBR.00016-10

De la Fuente-Núñez, C., & Hancock, R. E. (2015). Anti-biofilm peptides: From discovery to applications. Trends in Biotechnology, 33(10), 599-611.

Dong, L., & Zhang, X. (2018). Nanomedicine in infectious disease treatment: New strategies and challenges. Nanotechnology Reviews, 7(6), 587-601.

Eichenberger, E. M., & Thaden, J. T. (2019). Epidemiology and mechanisms of resistance of extensively drug-resistant Gram-negative bacteria. Antibiotics, 8(2), 37. https://doi.org/10.3390/antibiotics8020037

Fair, R. J., & Tor, Y. (2014). Antibiotics and bacterial resistance in the 21st century. Perspectives in Medicinal Chemistry, 6, 25-64.https://doi.org/10.4137/PMC.S14459

Fakruddin, M., Prima, M.J., Chowdhury, T., Ferdous, U.T., Afroz, J., & Shishir, M.A.S. (2024). Nature's Tiny Chemists: Microorganisms as Sources of Next-Gen Active Pharmaceutical Ingredients (APIs). Journal of Primeasia, 5(1), 1-9.https://doi.org/10.9928/primeasia.2024.9

Farhadi, R., Saffar, M. J., Monfared, F. T., Larijani, L. V., Kenari, S. A., & Charati, J. Y. (2022). Prevalence, risk factors and molecular analysis of vancomycin-resistant Enterococci colonization in a referral neonatal intensive care unit: A prospective study in northern Iran. Journal of Global Antimicrobial Resistance, 30, 63–68. https://doi.org/10.1016/j.jgar.2022.06.004

Fatima, K.B., Salam, M.T., Biswash, M.A.R., Rana, M.S., Das, S.S., Hossian, M., Bashir, M.S., Sikder, N.F., Shahin, H.R., Ali, R., & Uddin, N. (2024). Assessing the Predictive Accuracy of IL-6, CRP, PCT, and D-Dimer for Mortality in COVID-19 ICU Patients. Journal of Primeasia, 5(1), 1-8. https://doi.org/10.9917/primeasia.2024.8

Flemming, H. C., Wingender, J., Szewzyk, U., Steinberg, P., Rice, S. A., & Kjelleberg, S. (2016). Biofilms: An emergent form of bacterial life. Nature Reviews Microbiology, 14(9), 563–575. https://doi.org/10.1038/nrmicro.2016.94

Floss, H. G., & Yu, T. W. (2005). Rifamycin-mode of action, resistance, and biosynthesis. Chemical Reviews, 105(2), 621–632. https://doi.org/10.1021/cr030112j

Franzosa, E. A., et al. (2015). Identifying personal microbiomes using metagenomic codes. Proceedings of the National Academy of Sciences, 112(22), 6278-6283.https://doi.org/10.1073/pnas.1423854112

Gh.AL-Abbasy, E., & Jalal, A.G. (2024). Lactoferrin Supplementation Induced Awassi Lambs Production with High Immunity and Iron Levels. Journal of Primeasia, 5(1), 1-7. https://doi.org/10.25163/primeasia.519765

Ghosh, P. R., Afnan, M., et al. (2023). Neurocybernetic assistive technologies to enhance robotic wheelchair navigation. Journal of Primeasia, 4(1), 1-6. https://doi.org/10.25163/primeasia.4140044

Ghosh, P. R., Halder, S., et al. (2024). Impact of generative AI models on neurocybernetics for enhancing brain-computer interface adaptability in motor disabilities. Journal of Primeasia, 4(1), 1-6.https://doi.org/10.25163/primeasia.4140047

Ghosh, P. R., Moin, M. G. H., et al. (2023). Surgical robotics enhanced by 3D reconstruction for minimally invasive bicuspid aortic valve replacement surgery. Journal of Primeasia, 4(1), 1-6.  https://doi.org/10.25163/primeasia.4140043

Goel, N., Fatima, S. W., Kumar, S., Sinha, R., & Khare, S. K. (2021). Antimicrobial resistance in biofilms: Exploring marine actinobacteria as a potential source of antibiotics and biofilm inhibitors. Biotechnology Reports, 30, e00613. https://doi.org/10.1016/j.btre.2021.e00613

Guerra, M. E. S., Destro, G., Vieira, B., Lima, A. S., Ferraz, L. F. C., Hakansson, A. P., et al. (2022). Klebsiella pneumoniae biofilms and their role in disease pathogenesis. Frontiers in Cellular and Infection Microbiology, 12, 877995. https://doi.org/10.3389/fcimb.2022.877995

Hegstad, K., Mikalsen, T., Coque, T. M., Werner, G., & Sundsfjord, A. (2010). Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium. Clinical Microbiology and Infection, 16(6), 541–554. https://doi.org/10.1111/j.1469-0691.2010.03226.x

Ioannou, P., Baliou, S., & Samonis, G. (2024). Nanotechnology in the Diagnosis and Treatment of Antibiotic-Resistant Infections. Antibiotics, 13(2), 121. https://doi.org/10.3390/antibiotics13020121

Jani, K., Srivastava, V., Sharma, P., Vir, A., & Sharma, A. (2021). Easy access to antibiotics; spread of antimicrobial resistance and implementation of one health approach in India. Journal of Epidemiology and Global Health, 11(4), 444–452. https://doi.org/10.2991/jegh.k.210823.001

Kållberg, C., Salvesen Blix, H., & Laxminarayan, R. (2019). Challenges in antibiotic R&D calling for a global strategy considering both short- and long-term solutions. ACS Infect Dis, 5, 1265–1268. https://doi.org/10.1021/acsinfecdis.9b00147

Kang, M., Yang, J., Kim, S., Park, J., Kim, M., & Park, W. (2022). Occurrence of antibiotic resistance genes and multidrug-resistant bacteria during wastewater treatment processes. Sci Total Environ, 811, 152331. https://doi.org/10.1016/j.scitotenv.2021.152331

Karygianni, L., Ren, Z., Koo, H., & Thurnheer, T. (2020). Biofilm matrixome: Extracellular components in structured microbial communities. Trends in Microbiology, 28(8), 668–681. https://doi.org/10.1016/j.tim.2020.02.004

Kishk, R. M., Abd El-Ghany, S. M., & El-Mohandes, M. A. (2021). Antibiotic resistance of Staphylococcus aureus isolated from dry food products. Journal of Food Safety, 41(4), e12912. https://doi.org/10.1111/jfs.12912

Kishk, R., Soliman, N., Nemr, N., Eldesouki, R., Mahrous, N., Gobouri, A., et al. (2021). Prevalence of aminoglycoside resistance and aminoglycoside modifying enzymes in Acinetobacter baumannii among intensive care unit patients, Ismailia, Egypt. Infection and Drug Resistance, 14, 143–150. https://doi.org/10.2147/IDR.S283349

Krell, T., & Matilla, M.A. (2022). Antimicrobial resistance: Progress and challenges in antibiotic discovery and anti-infective therapy. Microb Biotechnol, 15, 70–78. https://doi.org/10.1111/1751-7915.13851

Lamberte, L.E., & van Schaik, W. (2022). Antibiotic resistance in the commensal human gut microbiota. Curr Opin Microbiol, 68, 102150. https://doi.org/10.1016/j.mib.2022.102150

Laxminarayan, R., et al. (2013). Antibiotic resistance: The need for global solutions. The Lancet Infectious Diseases, 13(12), 1057-1098.https://doi.org/10.1016/S1473-3099(13)70318-9

Liu, J., Gefen, O., Ronin, I., Bar-Meir, M., & Balaban, N. Q. (2020). Effect of tolerance on the evolution of antibiotic resistance under drug combinations. Science, 367(6474), 200–204. https://doi.org/10.1126/science.aaz5487

Liu, Y., & Zhao, X. (2016). Role of reactive oxygen species in antibiotic resistance. Antimicrobial Agents and Chemotherapy, 60(6), 3203-3211.

Liu, Y., Jia, Y., Yang, K., & Wang, Z. (2020). Heterogeneous strategies to eliminate intracellular bacterial pathogens. Frontiers in Microbiology, 11, 563. https://doi.org/10.3389/fmicb.2020.00563

Lopatkin, A. J., Bening, S. C., Manson, A. L., Stokes, J. M., Kohanski, M. A., Badran, A. H., et al. (2021). Clinically relevant mutations in core metabolic genes confer antibiotic resistance. Science, 371(6526), eaba0862. https://doi.org/10.1126/science.aba0862

Mahoney, A. R., Safaee, M. M., Wuest, W. M., & Furst, A. L. (2021). The silent pandemic: Emergent antibiotic resistances following the global response to SARS-CoV-2. iScience, 24(3), 102304. https://doi.org/10.1016/j.isci.2021.102304

Makabenta, J.M.V., Nabawy, A., Li, C.H., Schmidt-Malan, S., Patel, R., & Rotello, V.M. (2021). Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections. Nat Rev Microbiol, 19, 23–36. https://doi.org/10.1038/s41564-020-00781-7

Malik, M., & Drlica, K. (2010). Control of infectious diseases by inhibiting bacterial persistence. Nature Reviews Microbiology, 8(12), 765-772.

Morar, M., & Wright, G. D. (2010). The genomic enzymology of antibiotic resistance. Annual Review of Genetics, 44, 25–51. https://doi.org/10.1146/annurev-genet-102209-163503

Ndayishimiye, J., Kumeria, T., Popat, A., Falconer, J.R., & Blaskovich, M.A.T. (2022). Nanomaterials: The new antimicrobial magic bullet. ACS Infect Dis, 8, 693–712. https://doi.org/10.1021/acsinfecdis.2c00072

Nicoloff, H., Hjort, K., Levin, B. R., & Andersson, D. I. (2019). The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification. Nature Microbiology, 4(3), 504–514. https://doi.org/10.1038/s41564-018-0342-0

O’Neill, J. (2016). Tackling drug-resistant infections globally: Final report and recommendations. Review on Antimicrobial Resistance. https://amr-review.org/

Pal, C., et al. (2015). Metal resistance and its association with antibiotic resistance. Advances in Microbial Physiology, 65, 261-313.https://doi.org/10.1016/bs.ampbs.2017.02.001PMid:28528649

Peterson, E., & Kaur, P. (2018). Antibiotic resistance mechanisms in bacteria: Relationships between resistance determinants of antibiotic producers, environmental bacteria, and clinical pathogens. Frontiers in Microbiology, 9, 2928. https://doi.org/10.3389/fmicb.2018.02928

Plackett, B. (2020). Why big pharma has abandoned antibiotics. Nature, 586, S50–S52. https://doi.org/10.1038/d41586-020-02834-2

Poole, K. (2012). Bacterial stress responses as determinants of antimicrobial resistance. Journal of Antimicrobial Chemotherapy, 67(9), 2069-2089.https://doi.org/10.1093/jac/dks196

Redgrave, L. S., Sutton, S. B., Webber, M. A., & Piddock, L. J. V. (2014). Fluoroquinolone resistance: Mechanisms, impact on bacteria, and role in evolutionary success. Trends in Microbiology, 22(8), 438–445. https://doi.org/10.1016/j.tim.2014.04.007

Rodríguez-Martínez, J. M., Pascual, A., & Martínez-Martínez, L. (2010). Plasmid-mediated quinolone resistance: An update. Journal of Infection and Chemotherapy, 16(3), 149–182. https://doi.org/10.1007/s10156-010-0065-2

Rosas, N. C., & Lithgow, T. (2022). Targeting bacterial outer-membrane remodelling to impact antimicrobial drug resistance. Trends in Microbiology, 30(6), 544–552. https://doi.org/10.1016/j.tim.2022.01.009

Shinu, P., Mouslem, A.K.A., Nair, A.B., Venugopala, K.N., Attimarad, M., Singh, V.A., et al. (2022). Progress report: Antimicrobial drug discovery in the resistance era. Pharmaceuticals (Basel), 15(4), 413. https://doi.org/10.3390/ph15040413

Singh, R., Sreedharan, S. M., & Singh, S. P. (2014). Mechanisms for antibacterial activity of nanoparticles. In The Role of Nanotechnology in Combating Multi-Drug Resistant Bacteria (Fig. 2). ResearchGate. https://www.researchgate.net/figure/Mechanisms-for-antibacterial-activity-of-nanoparticles_fig2_261836341

Stalder, T., Rogers, L. M., Renfrow, C., Yano, H., Smith, Z., & Top, E. M. (2017). Emerging patterns of plasmid-host coevolution that stabilize antibiotic resistance. Scientific Reports, 7, 1–10. https://doi.org/10.1038/s41598-017-04989-1

Sulaiman, J. E., & Lam, H. (2021). Evolution of bacterial tolerance under antibiotic treatment and its implications on the development of resistance. Frontiers in Microbiology, 12, 617412. https://doi.org/10.3389/fmicb.2021.617412

Sun, F., et al. (2013). Enzymatic degradation of bacterial biofilm components. Applied Microbiology and Biotechnology, 97(20), 8411-8425.https://doi.org/10.1007/s00253-013-5110-8

Sun, J., Wang, L., Zhang, S., & Liu, F. (2013). Protease: Degrading bacterial biofilm by breaking down extracellular polymeric substances. Journal of Antimicrobial Chemotherapy, 68(3), 621-627. https://doi.org/10.1093/jac/dks456

Vanrompay, D., Nguyen, T.L.A., Cutler, S.J., & Butaye, P. (2018). Antimicrobial resistance in Chlamydiales, Rickettsia, Coxiella, and other intracellular pathogens. Microbiol Spectr, 6(2), 485–500. https://doi.org/10.1128/microbiolspec.ARBA-0001-2018

Wand, M. E., Bock, L. J., Bonney, L. C., & Sutton, J. M. (2022). Mechanisms of carbapenem resistance in clinically relevant Gram-negative bacteria. FEMS Microbiology Reviews, 46(1), fuab051. https://doi.org/10.1093/femsre/fuab051

Westblade, L. J., Errington, J., & Dorr, T. (2020). Antibiotic tolerance. PLoS Pathogens, 16(10), e1008892. https://doi.org/10.1371/journal.ppat.1008892

Worley, J. N., Javkar, K., Hoffmann, M., Hysell, K., Garcia-Williams, A., Tagg, K., et al. (2021). Genomic drivers of multidrug-resistant Shigella affecting vulnerable patient populations in the United States and abroad. mBio, 12(1), e03188-20. https://doi.org/10.1128/mBio.03188-20

Wright, G. D. (2005). Beta-lactamases: Modifying or deactivating beta-lactam antibiotics. Annual Review of Microbiology, 59, 291-315. https://doi.org/10.1146/annurev.micro.59.030804.121443

Yan, J., & Bassler, B. L. (2019). Surviving as a community: Antibiotic tolerance and persistence in bacterial biofilms. Cell Host & Microbe, 26(1), 15–21. https://doi.org/10.1016/j.chom.2019.06.002

Zhang, L., et al. (2010). Development of nanoparticles for antimicrobial drug delivery. Current Medicinal Chemistry, 17(6), 585-594.https://doi.org/10.2174/092986710790416290

Zou, J., & Shankar, N. (2016). The opportunistic pathogen Enterococcus faecalis resists phagosome acidification and autophagy to promote intracellular survival in macrophages. Cell Microbiol, 18, 831–843. https://doi.org/10.1111/cmi.12556